Search

Soluvos Medical wishes all readers an awesome New Year!

This year passed by so quickly and the Soluvos team is already preparing for next year’s meetings: 15–18 Jan ’25 Winter Days of Laryngology, Crans, Switzerland24–25 Jan ’25 Danish Laryngology Meeting, Nyborg, Denmark30–31 Jan ’25 Winter Laryngology Course on Laryngeal...

Landmark study at Homerton University Hospital confirms GastroPanel®’s diagnostic accuracy

BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients with upper abdominal complaints. This study demonstrated...

BIOHIT introduces the FAEX™ Sample System for stool sample collection and handling

BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow. Designed for precision, efficiency and flexibility, this innovative, practical...

One hundredth VOIS implant case completed

One hundred patients across the UK and Ireland have now benefited from an innovative vocal implant system designed to treat glottic insufficiency with voice and swallowing disorders. DP Medical Systems Ltd., the exclusive UK and Ireland distributor of the ‘VOIS...

Navient receives FDA 510(k) clearance for ENT procedures

CKI (ClaroNav Kolahi Inc.) has received FDA 510(k) clearance for Navient in ENT procedures, expanding its previous clearance for cranial applications. Navient is now approved by major global regulatory bodies, including Canada (HC), Europe (EU MDD), China (NMPA), UAE, Saudi...

Soluvos Medical is looking forward to catching up with readers

Having recharged their batteries and the Soluvos Medical team is looking forward to meeting readers again at the next symposia and hands-on courses. Pass by their booth to catch up and to meet their new Sales Manager - Marc de...

Neuromod advances multiple regulatory approvals to expedite Lenire’s global availability

Neuromod, the medical technology company that created the Lenire® tinnitus treatment device, has announced approval to the Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification. Neuromod’s MDSAP certification follows a comprehensive audit verifying compliance with...